Highline Wealth Partners’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.3K | Sell |
11
-13
| -54% | -$5.09K | ﹤0.01% | 478 |
|
|
2025
Q1 | $10.5K | Buy |
24
+14
| +140% | +$6.1K | ﹤0.01% | 302 |
|
|
2024
Q4 | $3.7K | Buy |
10
+5
| +100% | +$1.85K | ﹤0.01% | 383 |
|
|
2024
Q3 | $2.61K | Buy |
5
+1
| +25% | +$521 | ﹤0.01% | 430 |
|
|
2024
Q2 | $2.17K | Hold |
4
| – | – | ﹤0.01% | 384 |
|
|
2024
Q1 | $2.07K | Hold |
4
| – | – | ﹤0.01% | 327 |
|
|
2023
Q4 | $1.89K | Sell |
4
-22
| -85% | -$10.4K | ﹤0.01% | 304 |
|
|
2023
Q3 | $11.3K | Buy |
26
+22
| +550% | +$9.58K | 0.01% | 177 |
|
|
2023
Q2 | $1.78K | Sell |
4
-1
| -20% | -$444 | ﹤0.01% | 236 |
|
|
2023
Q1 | $2.3K | Buy |
5
+1
| +25% | +$460 | ﹤0.01% | 221 |
|
|
2022
Q4 | $2.05K | Hold |
4
| – | – | ﹤0.01% | 219 |
|
|
2022
Q3 | $1.82K | Buy |
+4
| New | +$1.82K | ﹤0.01% | 217 |
|